Anticancer effects of eleven triterpenoids derived from Antrodia camphorata

Yi-Pang Lee1, Wan-Chi Tsai, Chih-Jan Ko

  • 1Schools of Dentistry, Chung Shan Medical University, 110, Section 1, Chien-Kuo North Road, Taichung, Taiwan 40201, ROC.

Anticancer Research
|July 4, 2012
PubMed

Insights

Methyl antcinate A (MAA), a compound from Antrodia camphorata, shows potent anticancer activity against various human cancer cells. It induces apoptosis through a caspase-dependent pathway, suggesting potential for new drug development.

Area of Science:

  • Natural Products Chemistry
  • Pharmacology
  • Cancer Biology

Background:

  • Antrodia camphorata is a medicinal mushroom with known bioactive compounds.
  • Triterpenoids are a class of natural products with diverse biological activities, including anticancer properties.

Purpose of the Study:

  • To isolate and evaluate the selective cytotoxicity of Antrodia camphorata derivatives against various human cancer cell lines.
  • To investigate the mechanism of action of the most potent derivative, methyl antcinate A (MAA).

Main Methods:

  • Isolation of eleven triterpenoid derivatives from Antrodia camphorata.
  • In vitro cytotoxicity assays against 14 human cancer cell lines and 2 non-transformed cell lines.
  • Western blotting to analyze the expression of apoptosis-related proteins (Bcl-2, Bax, PARP) in PC-3 cells treated with MAA.

Main Results:

  • Methyl antcinate A (MAA) demonstrated potent and selective cytotoxicity against a broad spectrum of cancer cells, including oral, prostate, and breast cancer lines.
  • MAA induced apoptosis in PC-3 cells via the caspase-dependent cascade and the Bax-mediated mitochondrial pathway.
  • Other derivatives, including methyl antcinate B and dehydroeburicoic acid, also exhibited significant selective cytotoxic effects.

Conclusions:

  • MAA is a promising lead compound for developing novel anticancer drugs.
  • The findings support the potential of Antrodia camphorata derivatives in cancer therapy.
  • Further modifications of these triterpenoids could enhance their anticancer efficacy.

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Electron Transport Chain: Complex I and II01:46

Electron Transport Chain: Complex I and II

The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
Cancer Prevention02:59

Cancer Prevention

Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...